Henry Daniell, Pegasus Professor and Trustee Chair
Dr. Henry Daniell is an internationally known molecular biologist. He pioneered the chloroplast genetic engineering approach in the 1980s. He has developed vaccines for the top five diseases listed by the World Health Organization, including cholera, amebiasis, rotavirus and malaria, and bio-defense vaccines for anthrax and the plague. He also has developed a method for treating diabetes in mice that appears to eliminate the condition.
He has served as a biotechnology consultant to the United Nations, and he provided testimony to the U.S. Senate in 2007 on his work. He was elected to the National Academy of Sciences, Italy in 2004, a rare honor for Americans. Past members from the U.S. include Benjamin Franklin and Albert Einstein. He also is a fellow of the American Association for the Advancement of Science.
Daniell has secured more than $10 million in research grants and contracts, including funding from the National Institutes of Health and the U.S. Department of Agriculture. He also founded UCF’s first biotechnology company, Chlorogen Inc. He has written more than 150 articles, and he is the senior editor of the UK’s Plant Biotechnology Journal and Germany’s Biotechnology Journal.
Daniell has been featured in regional and national media, including The New York Times and Scientific American, as well as NBC, ABC, CBS, CNN and the Discovery Channel.